AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 131 filers reported holding AMNEAL PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $1,000 | -75.0% | 500 | 0.0% | 0.00% | -100.0% |
Q2 2019 | $4,000 | -42.9% | 500 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $7,000 | 0.0% | 500 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $7,000 | -36.4% | 500 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $11,000 | +37.5% | 500 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $8,000 | – | 500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fosun International Ltd | 19,552,001 | $433,859,000 | 20.80% |
BRIDGER MANAGEMENT, LLC | 2,642,621 | $58,640,000 | 3.39% |
TPG Group Holdings (SBS) Advisors, Inc. | 3,884,600 | $86,199,000 | 1.10% |
HUSSMAN STRATEGIC ADVISORS, INC. | 125,000 | $2,774,000 | 0.80% |
HealthCor Management, L.P. | 1,036,110 | $22,991,000 | 0.76% |
GW&K Investment Management, LLC | 2,049,765 | $45,484,000 | 0.73% |
Bridge City Capital, LLC | 50,434 | $1,119,000 | 0.70% |
TCW GROUP INC | 2,521,064 | $55,942,000 | 0.46% |
FRONTIER CAPITAL MANAGEMENT CO LLC | 2,876,367 | $63,827,000 | 0.41% |
Quadrant Capital Management, LLC | 25,002 | $555,000 | 0.35% |